Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients-Reference-Cited by-同舟云学术

Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients

Published:2015-01 Issue: Volume:113 Page:103-106
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Casado José L.,Bañón Sara,Rodriguez Miguel A.,Moreno Ana,Moreno Santiago

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference17 articles.

1. Combinations of nucleoside/nucleotide analogues for HIV therapy;Barreiro;AIDS Rev.,2004

2. Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy;Calin;Antiviral Ther.,2012

3. Liver toxicity in HIV-infected patients receiving novel second-generation nonnucleoside reverse transcriptase inhibitors etravirine and rilpivirine;Casado;AIDS Rev.,2013

4. Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART;Casado;HIV Clin. Trials,2013

5. A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz;Domingo;J. Acquir. Immune Defic. Syndr.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extractive determination study of Etravirine by using Tpooo as an Analytical reagent in Pure and Pharmaceutical dosage forms;Research Journal of Pharmacy and Technology;2022-03-24

2. Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV;Pharmaceuticals;2020-06-11

3. Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients;Journal of the International Association of Providers of AIDS Care (JIAPAC);2019-01-01

4. Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen;Journal of Antimicrobial Chemotherapy;2018-12-06

5. Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy;Drug Design, Development and Therapy;2018-11